Healthy Skepticism Library item: 6587

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Lexchin J, Vitry A.
MaLAM Letter follow up—Sandoz’s promotion of Parlodel (bromocriptine)
MaLAM International News 1995 Jun; 13:(6):1-8

Abstract:

MaLAM responded to Sandoz’s reply about its promotion of Parlodel for lactation suppression. MaLAM thinks that there are errors of fact and interpretation in Sandoz’s response. MaLAM is especially suprised about Sandoz’s refusal to provide MaLAM with copies of the references quoted in Sandoz’s letter.

Keywords:
*analysis/Pakistan/Canada/United States/France/developing countries/developed countries/Parlodel/ lactation suppression/Sandoz/quality of information/company responses/ safety & risk information/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: BREAST FEEDING AND CONTRACEPTION/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES